Considerations for Older Adults and Multiple Health Conditions Older adults with CKD often face multiple health challenges, making them more prone to drug interactions and side effects when starting GLP-1 therapy
Structured psychotherapeutic support for patients with mood disorders reinforces the mood and quality of life benefits of GLP-1 RAs by helping patients adhere to their treatment plan and promoting behavioral activation and reduction in weight- or metabolism-related avoidance or demoralization
The SURMOUNT trials show consistently greater weight loss with tirzepatide compared to semaglutide, but also steeper regain after discontinuation
Novos GLP-1 revenue generated around $35 billion in 2025, about 75% of the companys annual revenue
Red represents 29.47% of the total flux, green 28.8% and blue 6.83%, which, in relation to the total flux, yields beautiful warm, luminous colors